AstraZeneca has pulled out of meeting with the European Union to discuss delayed vaccine commitments to the bloc, a European Commission spokesperson said on Wednesday.
Dana Spinant confirmed earlier reports by the Reuters and AP news agencies that the firm had pulled out of tonight’s meeting with EU officials.
“The representative of AstraZeneca has announced this morning that their participation is not happening,” she told journalists.
The British-Swedish pharmaceutical giant has not yet commented.
A senior Commisson official told DW that they still expected the firm to take part in a meeting “in due course.”
What were AstraZeneca and the EU planning to talk about?
Executives were set to hold talks with the European Commission, which negotiated the vaccine deals, to explain the delay in deliveries.
The European Medicines Agency, which is based in Amsterdam, will take a decision on whether to approve the jab for use in the 27-member bloc on Friday.
It was developed together with scientists at the University of Oxford.
EU vaccine rollout under fire
On Monday, the EU threatened to impose tight export controls within days on COVID-19 vaccines made in the bloc.
The EU, which has 450 million citizens and the economic and political clout of the world’s biggest trading bloc, is lagging behind countries like Israel and Britain in rolling out coronavirus vaccine shots.
There have been more than 400,000 confirmed virus deaths in the EU since the pandemic began last year.
